These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 24416365)
21. Altomare A; Baron G; Brioschi M; Longoni M; Butti R; Valvassori E; Tremoli E; Carini M; Agostoni P; Vistoli G; Banfi C; Aldini G Antioxidants (Basel); 2020 Apr; 9(5):. PubMed ID: 32354002 [TBL] [Abstract][Full Text] [Related]
22. [Structure and function changes of oxidized human serum albumin: physiological significance of the biomarker and importance of sampling conditions for accurate measurement]. Yamada N; Nakayama A; Kubota K; Kawakami A; Suzuki E Rinsho Byori; 2008 May; 56(5):409-15. PubMed ID: 18546891 [TBL] [Abstract][Full Text] [Related]
23. Enrichment of cysteinyl adducts of human serum albumin. Funk WE; Li H; Iavarone AT; Williams ER; Riby J; Rappaport SM Anal Biochem; 2010 May; 400(1):61-8. PubMed ID: 20074543 [TBL] [Abstract][Full Text] [Related]
24. Albumin thiol oxidation and serum protein carbonyl formation are progressively enhanced with advancing stages of chronic kidney disease. Matsuyama Y; Terawaki H; Terada T; Era S Clin Exp Nephrol; 2009 Aug; 13(4):308-315. PubMed ID: 19363646 [TBL] [Abstract][Full Text] [Related]
25. Profiling Cys34 adducts of human serum albumin by fixed-step selected reaction monitoring. Li H; Grigoryan H; Funk WE; Lu SS; Rose S; Williams ER; Rappaport SM Mol Cell Proteomics; 2011 Mar; 10(3):M110.004606. PubMed ID: 21193536 [TBL] [Abstract][Full Text] [Related]
26. The thiol of human serum albumin: Acidity, microenvironment and mechanistic insights on its oxidation to sulfenic acid. Bonanata J; Turell L; Antmann L; Ferrer-Sueta G; Botasini S; Méndez E; Alvarez B; Coitiño EL Free Radic Biol Med; 2017 Jul; 108():952-962. PubMed ID: 28438657 [TBL] [Abstract][Full Text] [Related]
27. Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Terawaki H; Yoshimura K; Hasegawa T; Matsuyama Y; Negawa T; Yamada K; Matsushima M; Nakayama M; Hosoya T; Era S Kidney Int; 2004 Nov; 66(5):1988-93. PubMed ID: 15496170 [TBL] [Abstract][Full Text] [Related]
28. Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients. Mera K; Anraku M; Kitamura K; Nakajou K; Maruyama T; Tomita K; Otagiri M Hypertens Res; 2005 Dec; 28(12):973-80. PubMed ID: 16671336 [TBL] [Abstract][Full Text] [Related]
29. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Witko-Sarsat V; Friedlander M; Capeillère-Blandin C; Nguyen-Khoa T; Nguyen AT; Zingraff J; Jungers P; Descamps-Latscha B Kidney Int; 1996 May; 49(5):1304-13. PubMed ID: 8731095 [TBL] [Abstract][Full Text] [Related]
30. The interplay between copper(II), human serum albumin, fatty acids, and carbonylating agent interferes with Cys 34 thiol reactivity and copper binding. Penezić AZ; Aćimović JM; Pavićević ID; Jovanović VB; Takić M; Mandić LM J Biol Inorg Chem; 2019 Feb; 24(1):61-70. PubMed ID: 30456476 [TBL] [Abstract][Full Text] [Related]
31. Oxidative damage of albumin in advanced liver disease. Oettl K; Stadlbauer V; Petter F; Greilberger J; Putz-Bankuti C; Hallström S; Lackner C; Stauber RE Biochim Biophys Acta; 2008; 1782(7-8):469-73. PubMed ID: 18498776 [TBL] [Abstract][Full Text] [Related]
32. Spectroscopic analysis of the impact of oxidative stress on the structure of human serum albumin (HSA) in terms of its binding properties. Maciążek-Jurczyk M; Sułkowska A Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 136 Pt B():265-82. PubMed ID: 25448930 [TBL] [Abstract][Full Text] [Related]
33. Chromatographic analysis of acetohexamide binding to glycated human serum albumin. Joseph KS; Anguizola J; Jackson AJ; Hage DS J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2775-81. PubMed ID: 20829128 [TBL] [Abstract][Full Text] [Related]
34. Untargeted adductomics of Cys34 modifications to human serum albumin in newborn dried blood spots. Yano Y; Grigoryan H; Schiffman C; Edmands W; Petrick L; Hall K; Whitehead T; Metayer C; Dudoit S; Rappaport S Anal Bioanal Chem; 2019 Apr; 411(11):2351-2362. PubMed ID: 30783713 [TBL] [Abstract][Full Text] [Related]
35. Red blood cells protect albumin from cigarette smoke-induced oxidation. Colombo G; Rossi R; Gagliano N; Portinaro N; Clerici M; Annibal A; Giustarini D; Colombo R; Milzani A; Dalle-Donne I PLoS One; 2012; 7(1):e29930. PubMed ID: 22238677 [TBL] [Abstract][Full Text] [Related]
36. The cobalt-albumin binding assay: insights into its mode of action. Bar-Or D; Rael LT; Bar-Or R; Slone DS; Mains CW; Rao NK; Curtis CG Clin Chim Acta; 2008 Jan; 387(1-2):120-7. PubMed ID: 17964561 [TBL] [Abstract][Full Text] [Related]
38. Bioanalytical verification of V-type nerve agent exposure: simultaneous detection of phosphonylated tyrosines and cysteine-containing disulfide-adducts derived from human albumin. Kranawetvogl A; Küppers J; Siegert M; Gütschow M; Worek F; Thiermann H; Elsinghorst PW; John H Anal Bioanal Chem; 2018 Feb; 410(5):1463-1474. PubMed ID: 29322229 [TBL] [Abstract][Full Text] [Related]
39. Capillary zone electrophoresis and capillary electrophoresis-mass spectrometry for analyzing qualitative and quantitative variations in therapeutic albumin. Marie AL; Przybylski C; Gonnet F; Daniel R; Urbain R; Chevreux G; Jorieux S; Taverna M Anal Chim Acta; 2013 Oct; 800():103-10. PubMed ID: 24120174 [TBL] [Abstract][Full Text] [Related]
40. Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. Naldi M; Baldassarre M; Domenicali M; Giannone FA; Bossi M; Montomoli J; Sandahl TD; Glavind E; Vilstrup H; Caraceni P; Bertucci C J Pharm Biomed Anal; 2016 Apr; 122():141-7. PubMed ID: 26852162 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]